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Premature Skin Aging Features Rescued by Inhibition
of NADPH Oxidase Activity in XPC-Deficient Mice
Mohsen Hosseini1,2, Walid Mahfouf1,2, Martin Serrano-Sanchez1,2, Houssam Raad1,2, Ghida Harfouche1,2,
Marc Bonneu3, Stephane Claverol3, Frederic Mazurier1,2,4, Rodrigue Rossignol1,5, Alain Taieb1,2,4,6 and
Hamid Reza Rezvani1,2,4
Xeroderma pigmentosum type C (XP-C) is characterized mostly by a predisposition to skin cancers and
accelerated photoaging, but little is known about premature skin aging in this disease. By comparing young
and old mice, we found that the level of progerin and p16INK4a expression, b-galactosidase activity, and reactive
oxygen species, which increase with age, were higher in young Xpc / mice than in young Xpcþ /þ ones. The
expression level of mitochondrial complexes and mitochondrial functions in the skin of young Xpc / was as
low as in control aged Xpcþ /þanimals. Furthermore, the metabolic profile in young Xpc / mice resembled that
found in aged Xpcþ /þ mice. Furthermore, premature skin aging features in young Xpc / mice were mostly
rescued by inhibition of nicotinamide adenine dinucleotide phosphate oxidase 1 (NOX1) activity by using a
NOX1 peptide inhibitor, suggesting that the continuous oxidative stress due to overactivation of NOX1 has a
causative role in the underlying pathophysiology.
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INTRODUCTION
Progeroid syndromes are a group of diseases characterized by
signs of premature aging. They comprise diseases such as the
Hutchinson–Gilford progeria syndrome, xeroderma pigmento-
sum (XP), trichothiodystrophy (TTD), and the Cockayne
syndrome (CS). Most of them usually show only a limited
number of features of premature aging and include defects in
various DNA repair systems such as nucleotide excision repair
(NER), leading to the accumulation of DNA damage, which is
thought to be an important mediator of aging (Schumacher
et al., 2008; Capell et al., 2009; Kamenisch and Berneburg,
2009). NER is one of the most versatile DNA repair systems
and is responsible for removing a wide variety of helix-
distorting DNA lesions, including UV-induced photoproducts
and several forms of oxidative lesions. The absence or
dysfunction of NER proteins results in one of the following
distinct diseases: XP, TTD, and CS (Kraemer et al., 2007;
Cleaver et al., 2009).
The defects in XP patients fall into seven NER complementa-
tion groups: XP-A to XP-G and a separate group XP variant
(XP-V). XP patients may be homozygous or compound
heterozygous for the genetic changes in the genes involved
in NER. About 60% of XP patients have an early and severe
sun sensitivity that damages the skin and eyes (Lehmann et al.,
2011). XP-C, one of the more common forms in Europe,
United States of America, and Japan, is due to inactivation of
the xeroderma pigmentosum, complementation group C (XPC)
protein, which is involved in global genome repair
but not in transcription-coupled repair. Probably as a conseq-
uence of this, XP-C patients do not usually present extreme
sunburn reactions (Lehmann et al., 2011). In addition to
its role in NER of UV-induced damage, XPC has been
shown in several recent studies to have a protective role
against oxidative DNA damage (D’Errico et al., 2006; Melis
et al., 2013; Hosseini et al., 2014). We have reported
that XPC silencing in normal human keratinocytes leads
to the activation of NADPH oxidase (NOX), which, in turn,
triggers a disturbed redox homeostasis and mitochondrial
dysfunction in the context of cancer induction (Rezvani
et al., 2011a, b). In addition to tumoral transformation, both
oxidative stress and energy metabolism are also considered as
crucial in the aging process. Although still controversial,
studies have shown good correlations between aging and
increased mitochondrial production of reactive oxygen
species (ROS) in humans and animals (Cui et al., 2012).
Functional studies of mitochondria in aged humans
and animals suggest that the bioenergetic function of
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mitochondria declines with age (Muller-Hocker, 1989; Muller-
Hocker et al., 1993; Lesnefsky and Hoppel, 2006).
In this study, we sought whether XPC deficiency results in
clear premature skin aging features in mouse skin and what
the role of NOX might be in this process.
RESULTS
Xpc knockout results in increased expression of aging
biomarkers, elevation of steady-state ROS levels, and altered
metabolism
To test whether knockout of Xpc is associated with accelerated
aging, we first evaluated the expression of progerin in the skin
of young and old proficient and deficient XPC mice (Xpcþ /þ
and Xpc / , respectively; Figure 1a and b). Progerin is a
truncated version of lamin A protein, which is involved in
Hutchinson–Gilford progeria syndrome, a syndrome in
which patients suffer from premature aging of many organs
(De Sandre-Giovannoli et al., 2003; Eriksson et al., 2003). It
has been reported that the same molecular mechanism
responsible for Hutchinson–Gilford progeria syndrome is
activated in healthy cells during aging (Scaffidi and Misteli,
2006) and that progerin is more abundant in late-passage cells
and in the dermis of aged individuals (McClintock et al.,
2007), suggesting that progerin is a biomarker of physiological
aging, at least in the skin. Results showed that the progerin
level increased with age and that its expression was higher in
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Figure 1. Both aging and xeroderma pigmentosum, complementation group C deficiency lead to an increase in progerin and p16INK4a expression, senescence-
associated beta-galactosidase (SA-b-gal) activity, the reactive oxygen species (ROS) level, and NADPH oxidase NOX) activity in the skin. Skin biopsies were
taken from 4-month-old (young) and 1.5-year-old (old) XPC–proficient (Xpcþ /þ ) and -deficient (Xpc / ) mice (N¼ 12 mice in each group). (a) Total protein
extracts of skin biopsies were assessed by western blot for the expression of progerin and p16INK4a. b-Actin was used as a loading control. (b) The protein bands
corresponding to progerin and p16INK4a were quantified and normalized with b-actin. The average density±SD is presented as the relative value to the density
in young Xpc / mice. *Po0.05 for mice in each group versus young wild-type mice, 1Po0.05 for old versus young Xpc / mice. (c) Representative photo-
micrographs of dorsal skin sections of mice stained for SA-b-gal activity (blue) and counterstained with nuclear fast red (red). Arrows indicate SA-b-gal-positive
cells. (d) Percentage of skin sections with SA-b-gal-positive (þ ) or -negative ( ) activity. (e, f) Intracellular ROS levels were measured in keratinocytes isolated
from skin biopsies of young and old Xpcþ /þ and Xpc / mice using the cytoplasmic probe, CM-H2DCF-DA (e), or the mitochondrial probe, MitoSOX (f).
The average ROS level in young wild-type mice was set at 100%. The results were then compared with it and are expressed as the average percentage of young
wild-type mice±SD. (g) NOX activity was measured (relative light unit per mg protein) in skin biopsies of young and old Xpcþ /þ and Xpc / mice. Results were
normalized to young wild-type mice. *Po0.05 for each group versus young Xpcþ /þ and 1Po0.05 for old versus young Xpc / mice. Bar¼ 100mm.
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Xpc / mice than in wild-type mice (Figure 1a and b). We
next evaluated two classical biomarkers of aging, i.e., p16INK4a
expression (Krishnamurthy et al., 2004) and senescence-
associated beta-galactosidase (SA-b-gal) activity (Dimri et al.,
1995; Velarde et al., 2012). The p16INK4a level was increased
with age and was higher in young Xpc / than in young
wild-type mice (Figure 1a and b). SA-b-gal activity increased
significantly focally in several areas of the stratum corneum,
hair follicles, sebaceous glands, and very rarely in the basal
layers as a function of age and/or XP-C deficiency (Figure 1c
and d).
As oxidative stress has been shown to be important in aging,
we then verified whether ROS levels correlate with increased
expression of aging biomarkers. To this end, we measured
both cytoplasmic and mitochondrial steady-state levels of ROS
in keratinocytes isolated from young and old XP-C–proficient
and -deficient mice (Figure 1e and f). A significant increase in
both cytoplasmic and mitochondrial steady-state ROS levels
occurred in the old mice compared with the young ones.
Furthermore, the level of ROS was higher in Xpc / cells
than in Xpcþ /þ keratinocytes (Figure 1e and f). As we have
already demonstrated that NOX overactivation is the mechan-
ism underlying XPC downregulation–induced enhancement of
ROS generation in human keratinocytes (Rezvani et al.,
2011a, b), we investigated whether NOX activity was
modified during aging. NOX activity increased significantly
with age and was higher in the skin of Xpc / mice than in
wild-type counterparts (Figure 1g).
As both cellular redox status and aging have been described
to affect mitochondrial energy metabolism (Rezvani et al.,
2011a; Furda et al., 2012), mitochondrial function was then
compared between young and old Xpc / and Xpcþ /þ mice
(Figure 2). Results indicated a marked decrease in the relative
expression level of the complexes I subunit NDUFB8, II
subunit SDHB, and III subunit UQCRC2 in the skin of old
wild-type mice compared with the young counterparts. Inter-
estingly, the relative expression level of these complexes in the
skin of young Xpc / was as low as that measured in the old
wild-type mice (Figure 2a–d). Complex IV (Figure 2e–g) and II
(Figure 2f and g) activities were also lower in the skin of aged
wild-type mice than in that of young wild-type mice. Activities
of these complexes in young Xpc / were significantly lower
than in the young wild-type mice (Figure 2e–g). Our results
further indicated that aging was associated with less oxygen
consumption and lower ATP content (Figure 2h and i). The
oxygen consumption rate and the ATP level in young Xpc /
mice were significantly lower than those in young wild-type
mice (Figure 2h and i).
To screen the effects of aging and the Xpc knockout on
metabolism profile, a quantitative proteomic approach was
used. Results showed a significant reduction in the expression
of several proteins involved in the pentose phosphate pathway,
the tricarboxylic acid cycle, mitochondrial oxidative phosphor-
ylation, and fatty acid b-oxidation during aging, as well as in
the skin of young Xpc / compared with young Xpcþ /þ mice
(Supplementary Table S1 and Supplementary Figure S1 online).
Taken together, our results suggest a premature onset of the
skin aging process in the youth of Xpc / mice.
Inhibition of NOX1/4 activity blocks premature skin aging
features in Xpc knockout mice
As there is now overwhelming evidence that cellular redox
status has an important role in aging (Kamenisch and
Berneburg, 2009; Cui et al., 2012), we speculated that NOX
overactivation–mediated increased ROS levels in XPC–defi-
cient mice could be the mechanism underlying the premature
skin aging profile. To elucidate this hypothesis, NOX inhibi-
tion in XPC–deficient mice could be helpful. To find an
inhibitor, we first investigated which NOXs among seven
members (NOX1 to NOX5, Duox1, and Duox2) of the NOX
family are expressed in mouse skin. Western blotting revealed
that NOX1, NOX2, and NOX4 (Figure 3a) but not the others
(data not shown) are expressed in it. Therefore, we first used
the pharmacological NOX inhibitor GKT137831, a specific
NOX inhibitor developed recently by GenKyoTex, which
has been shown to inhibit NOX1 and NOX4 with high affinity
and NOX2 with lower potency and almost without any
affinity for xanthine oxidase and other ROS-producing and
redox-sensitive enzymes (Gaggini et al., 2011; Aoyama et al.,
2012). Although not affecting protein expression levels of
NOX1 and NOX4 (Supplementary Figure S2a online),
GKT137831 blocked their activity efficiently in both
Xpcþ /þ and Xpc / keratinocytes (Supplementary Figure
S2b online). We then examined whether oral administration of
the NOX inhibitor GKT137831 could block NOX activity in
mouse skin. To this end, we examined the effect of
GKT137831 on UVB-induced NOX activation and conse-
quent ROS generation, because we have already shown that
UVB irradiation results in an immediately increased ROS level
mediated by NOX activation (Rezvani et al., 2006, 2007).
Wild-type mice were treated with GKT137831 at 20 mg kg 1
per day by oral administration and then irradiated with
UVB. Measurement of NOX activity in mouse skin
immediately after irradiation showed that this dose can
efficiently block UVB-induced NOX activation (Figure 3b),
as well as NOX-dependent ROS production following UVB
irradiation (Figure 3c).
To investigate the role of NOX activity on premature skin
aging in XP-C–deficient mice, 1-month-old Xpcþ /þ and
Xpc / mice were treated daily by oral administration of
placebo or GKT137831 for 3 months. As shown in Figure 3d,
treatment of Xpc / mice with GKT137831 restored NOX
activity to the level observed in treated Xpcþ /þ mice. In fact,
following treatment with GKT137831, a reduction in NOX
activity was seen even in wild-type mice, which could be
attributed to the residual activity of NOX family members.
However, the level of NOX activity was approximately the
same in GKT137831-treated XPC–deficient and proficient
mice. That treatment also blocked Xpc knockout–induced
increased cytoplasmic and mitochondrial ROS levels
(Figure 3e and f). Evaluation of aging biomarkers in mice
treated with placebo or GKT137831 revealed that NOX
inhibition completely blocked XPC downregulation–induced
increased progerin and p16INK4a expression, as well as
enhanced SA-b-gal activity (Figure 3g–j).
Treatment of Xpc / mice with GKT137831 abrogated the
decreased expression of oxidative phosphorylation complexes
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I, II, and III in Xpc / mice (Figure 4a–d) and restored the
activity of complex IV (Figure 4e–g) and II (Figure 4f and g) to
the level found in Xpcþ /þ mice. Similarly, the oxygen
consumption rate and the ATP level in the skin of Xpc /
mice treated with GKT137831 resembled that of the placebo-
treated Xpcþ /þ (Figure 4h and i).
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Figure 2. Xeroderma pigmentosum, complementation group C (XPC) deficiency results in mitochondrial function deficiency. (a) Expression of oxidative
phosphorylation (OXPHOS) complexes was assessed by western blot analysis in young and old proficient and deficient XP-C mice. (b–d) The bands corresponding
to different OXPHOS complexes were quantified and normalized with b-actin. The average density±SD is presented as the relative value to the density in young
wild-type mice. (e) Complex IV activity was measured in young and old mice. The average level of complex IV activity in young wild-type mice was set at 100%.
The results were then normalized to the young wild-type mice. (f) Representative photomicrographs of dorsal skin sections stained for cytochrome c oxidase (COX)
activity (brown color) and succinate dehydrogenase (SDH) activity (blue color). (g) Percentage of skin sections with high and low COX and SDH activity. Oxygen
consumption (h) and total endogenous ATP levels (i) were measured in young and old mice. The average level of each factor in young wild-type mice was set at
100%. The results were then normalized to the young wild-type mice. N¼ 12 mice in each group. *Po0.05 for each group versus young Xpcþ /þ and 1Po0.05 for
old versus young Xpc / mice. Bar¼ 100mm.
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A peptide targeting NOXO1 and NOXA1 interaction blocks
NOX1 activity specifically
Although NOX1 and NOX4 are very similar, their functions
appear to be non-redundant (Bedard and Krause, 2007).
Therefore, we sought to identify which NOX could block
premature skin aging features in XPC–deficient mice. The
greatest challenge, however, was developing a specific NOX1
or NOX4 inhibitor, which does not yet exist. Despite their
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similar structure, NOX1 and NOX4 differ in their mechanism
of activation. Although NOX4 requires p22phox and perhaps
Rac as its subunits, NOX1 consists of five heterosubunits
(NOX1, p22phox, NOXA1, NOXO1, and the small GTPase
Rac), which, when activated, associate to form an active
enzyme complex generating O2
– from oxygen using NADPH
as an electron donor (Bedard and Krause, 2007). We specu-
lated that a selective NOX1 inhibition could be achieved by
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blocking the assembly of the NOX1 complex. To examine this
hypothesis, we tested various peptide inhibitors targeting the
proline-rich region of human NOXO1 or the SH3 domain of
human NOXA1 (data not shown). We found one peptide,
hereafter called InhNOX, that blocks NOX1 activity in human
and mice (Supplementary Figures S3, S4 and S5 online). The
InhNOX peptide comprises a tat sequence (R-K-K-R-R-Q-R-R-
R), which is N-terminal to the sequence P-P-T-V-P-T-R-P-S. A
scramble peptide (tat-V-T-P-P-T-S-R-P-P) was used as control.
Initially, the trypan blue exclusion assay and the MTT assay
were used to evaluate the cytotoxic effects of each peptide.
No significant cytotoxicity was observed after treatment with
less than 50mM of peptides (Supplementary Figure S3a and b
online). To examine the efficiency and the specificity of this
peptide, NOX activity and ROS levels were first assessed in
HT29 cells in which NOX1 is the only active member of the
NOX family (Gianni et al., 2008). Results showed that
treatment with InhNOX resulted in a significant reduction in
NOX activity and ROS levels (Supplementary Figure S4a and b
online). To examine further the specificity of InhNOX peptide,
keratinocytes in which the expression of endogenous NOX1,
NOX2, and NOX4 protein was inhibited by using shRNA
technology were treated with InhNOX. Equally decreased
NOX activity and ROS levels were found in shNOX1-
transduced cells, InhNOX-treated cells, and shNOX1-trans-
duced cells treated with InhNOX, demonstrating that InhNOX
blocked NOX1-dependent ROS generation with very high
(near 100%) efficiency and specificity (Supplementary Figure
S5a and b online).
To evaluate whether this peptide had an inhibitory effect on
NOX1 activity in mouse skin, we first compared the effect of
InhNOX on NOX activity in human and mouse keratinocytes.
Results revealed 40% and 37% reduction in NOX activity,
respectively, in human and mouse keratinocytes treated
with InhNOX (Supplementary Figure S5c online), suggesting
a similar preventive effect of InhNOX on NOX activity in
human and mouse cells. To determine the efficient dose of
InhNOX in vivo, mice were then treated topically with
different doses of InhNOX and skin biopsies were harvested
at different times post treatment. Results showed that InhNOX
inhibited NOX activity efficiently for up to 48 hours when
administered at 3 and 12 mg kg1 (Supplementary Figure S5d
online). The effect of InhNOX on UVB-irradiated mice was
then tested to find the optimal topical dose of the peptide
inhibitor upon stimulation. Results showed that topical appli-
cation of InhNOX at 3 and 12 mg kg 1 efficiently blocked
UVB-induced NOX activation in mouse skin (Supplementary
Figure S5e and f online).
Taken together, our results demonstrate that InhNOX,
as a novel NOX1 inhibitor, is able to inhibit NOX1 activa-
tion efficiently in human and mouse cells in vitro and
in vivo.
Inhibition of NOX1 activity blocks premature skin aging features
in Xpc knockout mice
To investigate whether NOX1 activity affects premature skin
aging in XPC–deficient mice, 1-month-old mice were treated
with scrambled peptide or InhNOX for 3 months. Results
showed that InhNOX treatment blocked XPC knockout–
induced NOX activation (Figure 5a), elevation of ROS levels
(Figure 5b and c), increased progerin and p16INK4a expression
(Figure 5d and e), and enhanced SA-b-gal activity (Figure 5f
and g). This treatment also restored the expression of oxidative
phosphorylation complexes I, II, and III (Figure 5h–k), the
activities of complexes IV and II (Figure 5l–n), the oxygen
consumption rate (Figure 5o), and ATP levels (Figure 5p) to
those found in the skin of Xpcþ /þ mice.
A quantitative proteomic approach was finally used to
assess the effects of NOX1 inhibition on modifications to the
XP-C deficiency–induced metabolic profile. Results showed
that treatment of mice with InhNOX restored the majority of
the observed modifications in young Xpc / mice to the level
found in the skin of young wild-type mice (Supplementary
Table S1 and Supplementary Figure S1 online).
Altogether, these results indicate that inhibition of NOX1
activity blocks XPC deficiency–induced premature skin aging.
DISCUSSION
Our results clearly demonstrate the premature onset of the skin
aging process in the youth of Xpc / mice. The increased risk
of developing internal cancers in XP-C patients (Kraemer et al.,
1987), the age-dependent accumulation of oxidative stress–
mediated spontaneous lesions in the Hprt gene (Wijnhoven
et al., 2000), the increased incidence of spontaneous lung and
liver tumors in old Xpc / mice (Hollander et al., 2005;
Wijnhoven et al., 2007; Melis et al., 2008), and the significant
shorter life span of Xpc / mice compared with wild-type
counterparts (Wijnhoven et al., 2007; Melis et al., 2008) all
suggest that XPC deficiency induces a mild premature aging
phenotype, which is in agreement with our results.
ROS in NER deficiency–induced premature aging
Sever progeroid syndromes in patients with a deficiency in the
transcription-coupled repair sub-pathway of NER suggest that
transcriptional impediments might be particularly relevant to
the aging process (Capell et al., 2009; Cleaver et al., 2009).
However, comparing premature aging features in NER diseases,
including XP, TTD, and CS, suggests that inactivation of NER
alone is not sufficient to cause progeroid features. Complete
inactivation of NER due to deficiency in XP-A in Xpa /
mice, e.g., does not cause CS- and TTD-like progeroid features
but instead leads to a very mild aging phenotype. Therefore, it
has been proposed that accelerated aging in CS and TTD
could be related to the impaired repair of oxidative DNA
damage (Andressoo et al., 2006, 2009; Cleaver et al., 2009).
Premature skin aging features in Xpc / mice could be also
related to XPC deficiency–induced oxidative DNA damage
because several studies have already highlighted the protec-
tive role of XP-C against oxidative DNA damage. This
protective function of XPC has been ascribed to its ability to
affect the key base-excision repair enzymes (Shimizu et al.,
2003; D’Errico et al., 2006), catalase activity (Vuillaume et al.,
1992), and/or NOX activity (Rezvani et al., 2011a; Hosseini
et al., 2014). In agreement with our data suggesting the exi-
stence of oxidative stress in Xpc / mice, it has been
reported that spontaneous mutation frequencies in the Hprt
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gene are 30-fold higher in the spleen of Xpc / mice as
compared with normal mice and that the majority of these
mutations result from oxidative damage (Wijnhoven et al.,
2000). Moreover, Xpc / mice harbor a slow accumulation
of mutations upon pro-oxidant exposure (Melis et al., 2013).
The effects of NOX1 activation in XP-C deficiency–induced
premature skin aging features
To identify the molecular events associated with aging, the
age-related modifications of the gene expression profile have
been studied in various mouse tissues (Cao et al., 2001; Lee
et al., 2002). Results revealed that aging is particularly asso-
ciated with modifications in the expression of genes involved
in stress responses, as well as a clear decline in the expression
of metabolic and biosynthetic genes. Consistently, our results
indicate an aging-associated decrease in mitochondrial
respiratory proteins and function, as well as a marked decline
in several proteins involved in the tricarboxylic acid cycle, the
pentose phosphate pathway, and fatty acid b-oxidation,
leading ultimately to lower ATP production. Decreased ATP
levels could, in turn, reduce the efficiency of the turnover of
damaged molecules, leading to the features of aging. In fact,
one of the mechanisms explaining aging could be oxidative
stress–mediated alterations in mitochondrial functions (Cui
et al., 2012). The effect of oxidative stress on mitochondrial
function has been related to a deficiency in mitochondrial
respiration during cell growth due to somatic mutations in
mtDNA (Cui et al., 2012). It is becoming increasingly clear
that mtDNA mutations can induce mild aging phenotypes in
mice with a wild-type nuclear genome (Ross et al., 2013). Our
present results indicate that the activation of NOX1 in Xpc /
mice results in a decline in mitochondrial metabolism because
of increased ROS levels. It is likely that NOX1 activation–
induced increased ROS leads to enhanced oxidation of
nuclear and mtDNA followed by the induction of mtDNA
deletions and alterations in mitochondrial bioenergetics.
Importantly, all these modifications (i.e., increased aging
biomarkers and ROS levels, as well as metabolic profile
alteration) can be mitigated by a treatment with the small-
molecule NOX inhibitor GKT137831 or NOX1 peptide
inhibitor, indicating that NOX1 activation–induced ROS
generation is the major cause of the premature skin aging
phenotype in Xpc / mice.
Conclusion and perspectives
Regarding the mechanism linking NOX1 activation and XPC
expression, we have already shown that accumulation of
unrepaired damaged DNA bases in XPC–deficient cells could
result in activation of the non-homologous end joining repair
pathway and subsequently the AKT pathway, which in turn
mediates induction of NADPH oxidase (Rezvani et al., 2011a).
The activation of NOX1 in XPC–deficient cells triggers
neoplastic transformation of keratinocytes (Rezvani et al.,
2011a), as well as premature skin aging. Further studies are
needed to identify the effect of the NOX1 inhibitor on the
life span of XPC / mice, as well as on UVB-induced skin
cancer.
MATERIALS AND METHODS
Transgenic mice
Xpc knockout mice originated from Cheo et al. (1997) and were a
generous gift from E.C. Friedberg (University of Texas Southwestern
Medical Center, Dallas, TX). Mice were bred and maintained in a
pathogen-free mouse facility at the Bordeaux University. All mouse
experiments were carried out with the approval of Bordeaux
University Animal Care and Use Committee.
Isolation of skin samples and keratinocytes
One part of the dorsal skin was excised and snap-frozen in
liquid nitrogen for western blotting and measurement of enzymatic
activities. The other part was used for isolation of keratinocytes.
To this end, the epidermis and dermis were separated by
trypsinization at 37 1C for 1 hour. Keratinocyte suspensions were
isolated from the epidermal sheet in Hank’s balanced salt solution
on ice.
Western blotting procedure
Western blotting was performed as previously described (Rezvani
et al., 2011a, b). Briefly, equal amounts of total protein were resolved
by SDS-PAGE and electrophoretically transferred to polyvinylidene
difluoride membranes. The membranes were then incubated over-
night at 4 1C with a 1:1,000 dilution of the anti-progerin (Santa Cruz
Biotechnology, TEBU, Le Perray en Yvelines, France), anti-NOX1,
anti-b-actin (Sigma, Saint Quentin Fallavier, France), anti-NOX4
(Abcam, Paris, France), and anti-NOX2 (a generous gift of Dr Mark
T. Quinn, Montana State University) antibodies or a total oxidative
phosphorylation antibody cocktail (Abcam). After additional incuba-
Figure 5. Topical application of InhNOX restores xeroderma pigmentosum, complementation group C (XPC) deficiency–induced increased NADPH oxidase
(NOX) activation, the reactive oxygen species (ROS) level, and aging biomarkers and metabolism profile modifications. One-month-old Xpcþ /þ and Xpc /
mice were treated topically with 3 mg kg1 of scramble peptide or InhNOX three times per week for 3 months. NOX activity (a), cytoplasmic (b), and
mitochondrial (c) ROS were measured in mouse skin biopsies. The results were then compared with the wild-type (WT) mice treated with scramble peptide and are
expressed as the average percentage of these mice±SD. (d) The expression level of progerin and p16INK4a were assessed by western blot in skin biopsies. (e) The
protein bands corresponding to progerin and p16INK4a were quantified and normalized with b-actin. (f) Representative photomicrographs of dorsal skin sections
stained for senescence-associated beta-galactosidase (SA-b-gal) activity (blue) and counterstained with nuclear fast red (red). (g) Percentage of skin sections with
SA-b-gal-positive or -negative activity. (h) Total protein extracts of skin biopsies were assessed for expression of oxidative phosphorylation (OXPHOS) complexes
by western blot analysis. (i–k) The bands corresponding to different OXPHOS complexes were quantified and normalized with b-actin. (l) Complex IV activity was
measured in different groups of mice. (m) Representative photomicrographs of dorsal skin sections stained for cytochrome c oxidase (COX) activity (brown color)
and succinate dehydrogenase (SDH) activity (blue color). (n) Percentage of skin sections with high and low COX and SDH activity. Oxygen consumption (o) and
total endogenous ATP levels (p) were measured in different groups of mice. The average level of each factor in WT mice treated with scramble peptide was set at
100% and the results were then normalized to these mice. N¼ 12 mice in each group and *Po0.05 for each group versus scramble peptide-treated Xpcþ /þ .
Bar¼100mm.
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tion with a 1:10,000 dilution of an anti-Ig horseradish peroxidase–
linked antibody (Vector Laboratories, Biovalley S.A, Marne la Valle´e,
France) for 1 hour, blots were developed using the chemilumines-
cence ECL reagent (Perkin Elmer, Courtaboeuf, France).
Mitochondrial enzyme histochemistry
Skin samples were embedded in frozen optimum cutting temperature
medium, cut into 20mm sections, and subjected to histochemical
staining for the activities of COX and SDH. Briefly, sections were
reacted for 45 minutes at 37 1C with COX staining solution (4 mM
diaminobenzidine tetrahydrochloride, 100mM cytochrome c and
20mg ml 1 catalase in 0.2 M phosphate buffer, pH 7.0) or 40 minutes
at 37 1C with SDH media (1.5 mM nitroblue tetrazolium, 1 mM
sodium azide, 200mM phenazine methosulphate, 130 mM sodium
succinate, in 0.2 M phosphate buffer, pH 7.0).
SA-b-gal activity staining
Frozen optimum cutting temperature-embedded samples were cut
into 10mm sections, processed for SA-b-gal staining using the
Senescence Detection Kit (BioVision, Mountain View, CA), and
counterstained with nuclear fast red. Four fields were taken at  40
magnification for each skin section and three sections per animal
were analyzed. Skin sections with several SA-b-gal staining
(blue staining in at least two out of four fields) were considered as
a SA-b-gal-positive section.
Proteomic analysis
Sample preparation, nano-scale liquid chromatographic tandem mass
spectrometry analysis, database search, processing of results, and
label-free quantitative data analysis are detailed in the Supplementary
Data section.
NOX inhibitor GKT137831
This inhibitor is a member of the pyrazolopyridine dione family, is a
specific inhibitor of NADPH isoforms NOX1 and NOX4 (NOX1
Ki¼ 110 nmol l 1 and Nox4 Ki¼ 140 nmol l 1), and has been shown
to inhibit NOX1- and NOX4-derived ROS in vitro and in vivo
(Gaggini et al., 2011; Aoyama et al., 2012). For the purpose of oral
administration, GKT137831 was solubilized in de-ionized water
comprising 1.2% methyl cellulose (Sigma) and 0.1% polysorbate 80
(Sigma). This solution without GKT137831 was used as placebo
treatment.
Statistics
Student’s t-test was applied for statistical evaluation and a *P-value
of o0.05 was considered significant. Results are presented as
means±SD.
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